Baggen et al. came to a similar conclusion in a population of subjects with adult congenital heart disease (median age 33.0 years), who saw an additional prognostic value of serial NT-proBNP measurements most likely in subjects with elevated baseline concentrations [27]. The gene discussed is NPPB; the disease is congenital heart disease.